Quidel Corporation (QDEL) Social Stream



Quidel Corporation (QDEL): $72.40

0.48 (+0.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QUIDELORTHO CORP (QDEL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering QDEL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 2 $219 $155 $187 $69.86 167.68%
2022-02-22 3 $219 $130 $174.5 $69.86 149.79%
2022-05-05 2 $219 $136 $177.5 $69.86 154.08%
2022-06-17 3 $136 $110 $123 $69.86 76.07%
2022-08-04 4 $136 $86 $110.666 $69.86 58.41%
2022-08-09 4 $136 $86 $107.333 $69.86 53.64%
2022-09-19 5 $136 $86 $103 $69.86 47.44%

The Trend in the Analyst Price Target


Over the past 16 months, QDEL's average price target has gone down $69.75.

QDEL reports an average of 37.81% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-05 3 219 155 187.000 121.10 54.42%
2021-11-05 3 219 80 151.333 121.10 24.97%
2021-11-05 4 219 155 187.000 121.10 54.42%
2022-05-05 2 219 136 177.500 102.66 72.9%
2022-05-05 3 136 136 136.000 102.66 32.48%

QDEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.6 2 0 2 1 1 5

The Trend in the Broker Recommendations


Over the past 30 months, QDEL's average broker recommendation rating worsened by 0.93.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, QUIDELORTHO CORP's number of analysts covering the stock is greater than 158.28% of them.
  • QUIDELORTHO CORP's average analyst price target is greater than 1083.54% of Pharmaceutical Products stocks.
  • In the context of stocks in the large market cap category, QUIDELORTHO CORP's upside potential (average analyst target price relative to current price) is higher than 886.43% of them.
  • In the context of Pharmaceutical Products stocks, QUIDELORTHO CORP's variance in analysts' estimates is lower than -274.73% of them.

Stocks similar to QUIDELORTHO CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NTLA, IDXX, and ZTS.

What is the outlook for QDEL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4693 seconds.